WO2001079224A3 - Haplotypes du gene cyp8b1 - Google Patents

Haplotypes du gene cyp8b1 Download PDF

Info

Publication number
WO2001079224A3
WO2001079224A3 PCT/US2001/011946 US0111946W WO0179224A3 WO 2001079224 A3 WO2001079224 A3 WO 2001079224A3 US 0111946 W US0111946 W US 0111946W WO 0179224 A3 WO0179224 A3 WO 0179224A3
Authority
WO
WIPO (PCT)
Prior art keywords
cyp8b1
gene
haplotypes
disclosed
cyp8b1 gene
Prior art date
Application number
PCT/US2001/011946
Other languages
English (en)
Other versions
WO2001079224A2 (fr
Inventor
Steven C Bentivegna
Anne Chew
Julie Y Choi
Beena Koshy
J Claiborne Stephens
Original Assignee
Genaissance Pharmaceuticals
Steven C Bentivegna
Anne Chew
Julie Y Choi
Beena Koshy
J Claiborne Stephens
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Steven C Bentivegna, Anne Chew, Julie Y Choi, Beena Koshy, J Claiborne Stephens filed Critical Genaissance Pharmaceuticals
Priority to AU2001257021A priority Critical patent/AU2001257021A1/en
Publication of WO2001079224A2 publication Critical patent/WO2001079224A2/fr
Publication of WO2001079224A3 publication Critical patent/WO2001079224A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10Sequence alignment; Homology search
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Evolutionary Biology (AREA)
  • Zoology (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des nouveaux polymorphismes mononucléotidiques dans le gène humain VIIIB de la sous-famille du cytochrome P450 (CYP8B1) . L'invention concerne également divers génotypes, haplotypes et paires d'haplotypes pour le gène CYP8B1 existant dans la population. L'invention concerne également des compositions et des procédés permettant d'haplotyper et/ou de génotyper le gène CYP8B1 dans un individu. L'invention concerne également des polynucléotides renfermant un ou plusieurs des polymorphismes du CYP8B1 susmentionnés.
PCT/US2001/011946 2000-04-12 2001-04-12 Haplotypes du gene cyp8b1 WO2001079224A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001257021A AU2001257021A1 (en) 2000-04-12 2001-04-12 Haplotypes of the cyp8b1 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19640800P 2000-04-12 2000-04-12
US60/196,408 2000-04-12

Publications (2)

Publication Number Publication Date
WO2001079224A2 WO2001079224A2 (fr) 2001-10-25
WO2001079224A3 true WO2001079224A3 (fr) 2002-02-28

Family

ID=22725282

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/011946 WO2001079224A2 (fr) 2000-04-12 2001-04-12 Haplotypes du gene cyp8b1

Country Status (2)

Country Link
AU (1) AU2001257021A1 (fr)
WO (1) WO2001079224A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1560925A4 (fr) * 2002-06-13 2006-10-25 Wyeth Corp Inhibiteurs de l'activite genique inflammatoire et de la synthese de cholesterol
KR100921793B1 (ko) 2007-05-31 2009-10-16 대한민국 Cyp2c19를 암호화하는 유전자의 일배체형 분석키트
WO2014018375A1 (fr) 2012-07-23 2014-01-30 Xenon Pharmaceuticals Inc. Cyp8b1 et ses utilisations dans des méthodes thérapeutiques et diagnostiques

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GAFVELS M. ET AL.: "Structure and chromosomal assignment of sterol 12.alpha.-hydroxylase gene (CYP8B1) in human and mouse: Eukaryotic cytochrome P-450 gene devoid of introns", GENOMICS, vol. 56, 1999, pages 184 - 196, XP002949131 *

Also Published As

Publication number Publication date
WO2001079224A2 (fr) 2001-10-25
AU2001257021A1 (en) 2001-10-30

Similar Documents

Publication Publication Date Title
WO2002026768A3 (fr) Haplotypes du gene por
WO2001079229A3 (fr) Haplotypes du gene cxcr4
WO2002038589A3 (fr) Haplotypes du gene cyp2d6
WO2001079234A3 (fr) Haplotypes du gene apoe
WO2001079224A3 (fr) Haplotypes du gene cyp8b1
WO2001079230A3 (fr) Haplotypes du gene ugt1a1
WO2001077124A3 (fr) Haplotypes du gene apoa4
WO2001090123A3 (fr) Haplotypes du gene agtrl1
WO2002030951A3 (fr) Haplotypes du gene cyp1b1
WO2001079228A3 (fr) Haplotypes du gene f12
WO2002008425A3 (fr) Haplotypes du gene adrb3
WO2001077363A3 (fr) Haplotypes du gene impdh2
WO2002018414A3 (fr) Haplotypes du gène bf
WO2001079223A3 (fr) Haplotypes du gene akr1b1
WO2001079232A3 (fr) Haplotypes du gene mpl
WO2001079218A3 (fr) Haplotypes du gene calm1
WO2001079219A3 (fr) Haplotypes du gene ache
WO2002062820A3 (fr) Haplotypes du gene cyp27b1
WO2001077129A3 (fr) Haplotypes du gene apoc1
WO2001079974A3 (fr) Haplotypes du gene f9
WO2001079240A3 (fr) Haplotypes du gene rangap1
WO2001079237A3 (fr) Haplotypes du gene galr1
WO2001079221A3 (fr) Haplotypes du gene il8rb
WO2001077132A3 (fr) Haplotypes du gene il5
WO2001077131A3 (fr) Haplotypes du gene bglap

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WPC Withdrawal of priority claims after completion of the technical preparations for international publication

Ref country code: WO

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP